Immunophenotyping detected by flow cytometry and its clinical significance in acute myeloid leukemia
10.3760/cma.j.issn.1009-9921.2013.10.007
- VernacularTitle:流式细胞术检测急性髓系白血病免疫表型及其临床意义
- Author:
Jinjing ZHANG
;
Pingping WANG
;
Yi QU
;
Yan LI
- Publication Type:Journal Article
- Keywords:
Leukemia,myeloid,acute;
Immunophenotyping;
Flow cytometry
- From:
Journal of Leukemia & Lymphoma
2013;22(10):597-599
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the immunophenotypic characteristics of acute myeloid leukemia (AML)and its relationship with chemotherapy response.Methods The immunophenotyping was performrd by flow cytometry in 96 newly diagnosed AML patients.Results In 96 patients with AML,the myeloid antigens were mainly expressed including CD13(94/96,97.92％),CD117(86/96,89.58％),CD33(79/96,82.29％)respectively.The positive expression of stem/progenitor cell differentiation antigens were CD38 (92/96,95.83％),HLA-DR(72/96,75.00％)and CD34(60/96,62.50％).While CD34 and HLA-DR were fewly expressed in M3.The CD14 was only expressed in M4 and M5.The lymphocytic antigens had positive expression in the patients with AML,in which CD4 was 37.5％(36/96),CD7 was 22.92％(22/96)and CD2 was 10.42 ％(10/96).In 46 patients for treatment response analysis,total CR rate was 67.39％(31 /46).There was no significant difference of CR rates between the antigens positive group and negative group including CD33,CD117,CD11b,CD14,CD64,CD4,CD34 and HLA-DR.However,the CR rate was significantly lower in CD7 positive cases than CD7 negative ones,with statistically significance difference(P=0.01).Conclusions CD13,CD33and CD117 are the most common antigens in AML.The patients with the positive expression of CD7 have poor response to chemotherapy in AML.
